全文获取类型
收费全文 | 31554篇 |
免费 | 2460篇 |
国内免费 | 2159篇 |
专业分类
耳鼻咽喉 | 1194篇 |
儿科学 | 209篇 |
妇产科学 | 496篇 |
基础医学 | 918篇 |
口腔科学 | 223篇 |
临床医学 | 2978篇 |
内科学 | 4839篇 |
皮肤病学 | 261篇 |
神经病学 | 728篇 |
特种医学 | 700篇 |
外国民族医学 | 6篇 |
外科学 | 3235篇 |
综合类 | 5517篇 |
现状与发展 | 3篇 |
预防医学 | 1114篇 |
眼科学 | 857篇 |
药学 | 8129篇 |
31篇 | |
中国医学 | 3864篇 |
肿瘤学 | 871篇 |
出版年
2024年 | 83篇 |
2023年 | 488篇 |
2022年 | 918篇 |
2021年 | 1228篇 |
2020年 | 1093篇 |
2019年 | 949篇 |
2018年 | 1138篇 |
2017年 | 1097篇 |
2016年 | 1359篇 |
2015年 | 1325篇 |
2014年 | 2759篇 |
2013年 | 2523篇 |
2012年 | 2575篇 |
2011年 | 2705篇 |
2010年 | 2092篇 |
2009年 | 1736篇 |
2008年 | 1638篇 |
2007年 | 1680篇 |
2006年 | 1487篇 |
2005年 | 1277篇 |
2004年 | 932篇 |
2003年 | 815篇 |
2002年 | 701篇 |
2001年 | 586篇 |
2000年 | 433篇 |
1999年 | 380篇 |
1998年 | 284篇 |
1997年 | 247篇 |
1996年 | 239篇 |
1995年 | 182篇 |
1994年 | 170篇 |
1993年 | 115篇 |
1992年 | 93篇 |
1991年 | 123篇 |
1990年 | 112篇 |
1989年 | 70篇 |
1988年 | 77篇 |
1987年 | 59篇 |
1986年 | 39篇 |
1985年 | 63篇 |
1984年 | 53篇 |
1983年 | 40篇 |
1982年 | 40篇 |
1981年 | 32篇 |
1980年 | 20篇 |
1979年 | 28篇 |
1978年 | 26篇 |
1977年 | 20篇 |
1976年 | 11篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Ropivacaine, a new long–acting amino–amide local anaesthetic agent, and bupivacaine, in various concentrations with or without addition of adrenaline, were tested in a randomized, double–blind study using intradermal wheals. Ten non–smoking, healthy, young male volunteers participated. In series I plain solutions of ropivacaine (0.25%, 0.5%, 0.75% and 1%) and bupivacaine (0.25%, 0.5% and 0.75%) were injected intradermally and in series II the same concentrations, with the addition of adrenaline 5 ug ml-1 ( 1 :200 000), were used. The same volunteers took part in both series, with an interval of at least three weeks between the experiments. Saline was included as control in both series. Pin–pricking was used to assess the dermal analgesia. Plain solutions of ropivacaine produced significantly longer durations of dermal analgesia than did plain solutions of bupivacaine, in all tested concentrations. A significant increase in duration was seen for both local anaesthetics when adding adrenaline. Local vascular effects at the injected areas were determined by visual inspection (nil, pink, pale). Local blanching (pale) was significantly more frequent for plain solutions of ropivacaine, in all tested concentrations. Local redness (pink) was significantly more frequent with plain bupivacaine, in a dose–dependent relation. An initial redness was frequently observed for both local anaesthetics containing adrenaline, followed by blanching at most sites. 相似文献
102.
103.
提高抗肝癌药物的肝脏浓度并降低心脏,血液浓度的实验研究 总被引:1,自引:0,他引:1
实验研究结果表明:阿霉素(ADM)在采用推进法注射时,经肝血管或外周静脉途径二者的肝、心与血液浓度均无显著差别.如采用控速缓慢输注法,则经肝血管较经外周静脉在提高肝脏浓度方面具有显著效果,心脏内浓度也有一定程度降低。如在肝血管内输注时与血液净化联合应用,则更能提高上述要求。以上结果将为临床抗癌药介入治疗应用方法的开展提供依据和参考价值。 相似文献
104.
目的 探讨黄芪注射液对心力衰竭 (HF)的治疗效果。方法 选择 92例住院HF患者随机分为治疗组和对照组 ,对照组给予常规治疗 ,治疗组在常规治疗的基础上给予黄芪注射液 30ml加 5 %葡萄糖液 2 5 0ml,静滴 ,每日一次 ,共 2周。疗程结束后 ,观察心功能改善情况。结果 治疗组有效率 93.4 8% ,对照组有效率 71.74 % ,两组对比 ,差异显著 (P <0 .0 1)。结论 黄芪注射液对HF的治疗效果佳 ,副作用少 ,值得推广。 相似文献
105.
灯盏花素合力源精纯溶栓酶治疗不稳定型心绞痛30例 总被引:11,自引:5,他引:6
目的 :观察灯盏花素、力源精纯溶栓酶治疗不稳定型心绞痛 (UAP)的临床疗效。方法 :将 6 0例 UAP患者随机分为治疗组和对照组各 30例。治疗组给予灯盏花素、力源精纯溶酶加常规抗心绞痛治疗 ;对照组仅给予常规抗心绞痛治疗。分别观察 2组治疗前后的心绞痛发作及硝酸甘油用量的变化 ,检测静息心电图和血液流变学指标。结果 :治疗组在缓解心绞痛总有效率 (93.33% )、改善异常心电图及血液流变学指标、降低硝酸甘油用量〔(0 .4 5± 0 .15 ) m g/ d〕等方面均显著优于对照组。结论 :灯盏花素联合力源精纯溶栓酶治疗 U AP疗效优于常规西药治疗。 相似文献
106.
目的 探讨在十二指肠乳头括约肌切开 (EST)胆总管取石术前静注咪唑安定的可行性及价值。方法 将 71例拟行 EST胆总管取石患者随机分为咪唑安定组 (试验组 ) 5 1例和对照组 (2 0例 ) ,两组术前均给予 6 5 4 -2 (10 mg)静脉注射 ,试验组同时静脉注射咪唑安定 (3~ 5 mg)。观察两组患者的进镜时间、麻醉程度 ,患者的反应与配合程度、自身感受程度 ,同时监测患者的血压、心率、血氧饱和度。结果 试验组进镜时间缩短、镇静程度适中、患者自身感受好 ,与对照组比较 ,差异有显著性 (P<0 .0 1) ;患者心血管及呼吸参数无明显变化。结论 EST胆总管取石术前静脉注射咪唑安定可提高麻醉效果 ,有利于提高患者配合的依从性 ,对血压、心率、血氧饱和度无明显影响 相似文献
107.
参附注射液对肠缺血-再灌注大鼠肿瘤坏死因子α的影响 总被引:5,自引:0,他引:5
目的观察肿瘤坏死因子α(TNF-α)在大鼠肠缺血-再灌注损伤过程中的作用及参附注射液对TNF-α的影响,探讨参附注射液防治肠缺血-再灌注损伤机制。方法 SD大鼠随机分为肠缺血-再灌注组(IR组)、参附注射液预处理组(SF组)和假手术组(C组)。采用阻断肠系膜上动脉(SMA)的方法制造肠缺血-再灌注模型。分别测定各组动物血浆、肠组织TNF-α含量及血液动力学变化;光镜观察肠粘膜损伤情况。结果IR组再灌注后MAP下降,与C组和SF组比有显著性差异(P<0.01);SF组肠粘膜损伤程度减轻,与IR组比有显著性差异(P<0.01);SF组血浆及肠组织TNF-α水平降低,与IR组比有显著性差异(P<0.01)。结论参附注射液可明显防治大鼠肠缺血-再灌注导致的肠粘膜损伤,这种作用可能是通过抑制TNF-α的释放实现的。 相似文献
108.
M Daperno R Sostegni N Scaglione E Ercole C Rigazio R Rocca A Pera 《Digestive and liver disease》2004,36(1):21-28
BACKGROUND: Severe ulcerative colitis is potentially life threatening even though a policy of intensive medical management and early colectomy in recent years reduced mortality to almost zero. However, colectomy, with or without ileal-anal anastomosis, has its own problems (morbidity, pouchitis, cuffitis) and no reliable prognostic index of surgical outcome has been developed. Intravenous steroids are still the mainstay of medical therapy but their maximal duration before stating a 'treatment failure' has not been defined. AIM OF THE STUDY: To evaluate the effectiveness, safety and outcome of an intensive medical approach in a series of patients with severe ulcerative colitis. PATIENTS AND METHODS: One hundred and forty-nine episodes of severe ulcerative colitis in 115 patients admitted to a Gastroenterology Unit in a 7-year period were retrospectively evaluated. Intravenous glucocorticosteroids--methylprednisolone 1 mg/kg/day--and topical steroids were administered, and supportive treatments with intensive monitoring were extended to all the patients. Second-line strategies for steroid-refractoriness were prolonged glucocorticosteroids treatment, oral ciclosporin, infliximab or surgery. RESULTS: The median number of Truelove criteria at admission was 3 (range 2-5), median CRP 34 mg/l (range 10-196). Median follow-up after discharge was 49 months. In 84 (57%) episodes an early response was noted, while 65 (43%) did not respond within 10 days to the standard steroid treatment. In the non-responders group, 28 patients went into remission with a prolonged steroid treatment (slow responders); 15 patients were treated with ciclosporin (eight responders) and 6 with infliximab (four responders). A total of 24 colectomies was performed in this group of patients (in 21 cases within 30 days from admission). Slow responders showed lower albumin levels (P = 0.02), higher cumulative dose of glucocorticosteroids in the year prior to admission (P = 0.02) and higher age (P = 0.03), in comparison with early responders. Major complications were noted in four episodes which responded to medical treatment. Disease-related mortality was zero. CONCLUSIONS: Medical treatment and use of second-line therapies were effective in the present series of patients. A group of slow responders has been identified and, if an intensive medical monitoring is guaranteed, steroids can be safely prolonged after the first 10 days of treatment. Cumulatively, about 80% of the patients responded to short-term medical treatment, only 5% of the patients underwent colectomy in the follow-up period. Major adverse events were recorded in four patients, who had recovered completely after adequate medical treatment. 相似文献
109.
目的:探讨消痔灵注射在直肠内脱垂治疗中的临床应用及改良方法.方法:对38例直肠内脱垂患者行消痔灵直肠黏膜高位柱状注射治疗的临床资料进行分析总结.结果:术后随访1~24个月,治愈28例(占73.7%),好转7例(占18.4%),总有效率达92.1%.结论:消痔灵直肠黏膜高位柱状注射治疗直肠内脱垂具有操作简单、疗效可靠、并发症少、费用低廉的优点. 相似文献
110.
醒脑静注射液治疗缺血性中风急性期随机对照试验的系统评价 总被引:1,自引:0,他引:1
目的 系统评价醒脑静注射液治疗缺血性中风急性期的疗效及安全性。方法 集醒脑静注射液治疗缺血性中风急性期随机对照试验文献,筛选合格研究,应用Jadad评分法进行质量评价,运用异质性检验、Meta-分析、漏斗图分析、敏感性分析等方法统计相关数据。结果 项研究符合纳入标准,Jadad评分所有研究得分均低于3分,属低质量文献。Meta-分析结果显示,总有效率比较的相对危险度(RR值)=1.04,99%的可信区间(CI值)为(0.88,1.23)。结论 前尚无充分证据证实醒脑静注射液治疗缺血性中风急性期的疗效及安全性。要进一步验证醒脑静注射液治疗缺血性中风急性期的疗效及安全性,尚需进行设计合理、执行严格、多中心大样本且随访时间足够的随机对照试验。 相似文献